Company intelligence / Profile preview

1Globe Capital

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

1Globe Capital is a private investment firm, not a clinical stage company; it is notable as the largest shareholder of Sinovac Biotech, participating in management and governance disputes over Sinovac’s board and strategy since 2016.

Industry: Investors

Partnerships

Investment partnership with Sinovac Biotech via ownership

Beyond the preview

Go deeper on 1Globe Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1Globe Capital.

Explore the full profile